The Emerging Cancer Vaccine Market, 2nd Edition - Biologics Market Research

The Emerging Cancer Vaccine Market, 2nd Edition
Published Date: November 2006
Published By: Kalorama Information
Page Count: 270
Order Code: R566-343
Price: $3500 Online Download
#3500 Hard Copy Mail Delivery
$7000 Global Site License
#3800 Instant online Delivery plus 1 Hard Copy
Propelled by advances in molecular biology, the cancer vaccine industry is poised for unprecedented growth. This second edition of Kalorama?s groundbreaking 2003 study completely updates the market data and reviews the technological, clinical, and business trends that have shaped and reshaped this emerging field.
Specific segments covered in the report include:
Cervical cancer,
Colorectal cancer,
Lung cancer,
Lymphoma,
Melanoma,
Prostate cancer, and
Other cancers for which vaccines are in development.
Each market segment provides an overview, descriptions of products available and in development, market estimates and forecasts for 2007-2012 by product, and competitive analysis of leading developers, including forecasted market share for 2012. The report also includes statistical information on cancers by type worldwide and in the United States. Profiles of the following developers and marketers are also included:
Advaxis, Inc.
Antigenics, Inc.
Aphton Corporation
AVAX Technologies, Inc.
Biomira, Inc.
Biovest International, Inc.
Cell Genesys, Inc.
Dendreon Corporation
Favrille, Inc.
GenMax Corporation
Genitope Corporation
Genzyme
Geron Corporation
GlaxoSmithKline
IDM
Intracel
Large Scale Biology Corporation
Medarex, Inc.
MedImmune, Inc.
Merck & Company, Inc.
Northwest Biotherapeutics
Oxford Biomedica, Plc
Pharmexa Group
Progenics Pharmaceuticals, Inc.
Therion Biologics Corporation
Vical, Inc.
YM Biosciences, Inc.
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. Kalorama Information conducted interviews with dozens of key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and development representatives.